BIOL368/S19 Week 12
From OpenWetWare
Jump to navigationJump to search
- Weekly Assignments
- Individual Journal Entries
- Fatimah Alghanem Journal Entry Week 2
- Fatimah Alghanem Journal Entry Week 3
- Fatimah Alghanem Journal Entry Week 4
- Fatimah Alghanem Journal Entry Week 5
- Fatimah Alghanem Journal Entry Week 6
- Fatimah Alghanem Journal Entry Week 7
- DrugComboDB Review
- Fatimah Alghanem Journal Entry Week 9
- Fatimah Alghanem Journal Entry Week 10
- Fatimah Alghanem Journal Entry Week 11
- The Mutants Research Project Week 12
- Fatimah Alghanem Journal Entry Week 14
- Class Journal
BIOL368/F20 BIOL368/F20:People
Group Project
Acknolwdgements
- I acknowledge my professor, Kam D. Dahlquist, Ph.D., for discussing the assignment with me.
- I discussed with my partners, Macie M. Duran, JT Correy, and Yaniv Maddahi over Zoom, facetime and text to plan our presentation and our journal article.
Except for what is noted above, this individual journal entry was completed by me and not copied from another source. Falghane (talk) 17:11, 2 December 2020 (PST)
References
- Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., ... & Hastie, K. M. (2020). Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell, 182(4), 812-827.
- Leung, K., Pei, Y., Leung, G. M., Lam, T. T., & Wu, J. T. (2020). Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2. medRxiv.
- OpenWetWare. (2020). BIOL368/F20:Week 12. Retrieved 2 December 2020, from https://openwetware.org/wiki/BIOL368/F20:Week_12
- Fernández, A. (2020). Structural impact of mutation D614G in SARS-CoV-2 spike protein: enhanced infectivity and therapeutic opportunity. ACS medicinal chemistry letters, 11(9), 1667-1670.